may 17, 2018 -- the fda has approved the first in a new class of migraine drugs that aim to fight painful..
updated: may 18, 2018, 10.36 am ist
. is the place to come for breaking news, analysis and for stories that are just too interesting � or too entertaining � to pass up..
andrew kaye, head of policy at macmillan cancer support said it was �shocking� that a cancer patient had to wait 541 days for treatment.. at this, shehbaz reassured them that the interview was taken out of context. this is unedited, unformatted feed from the press trust of india wire..